Will Basta is scaling access to personalized wellness through digital platforms, peptide therapy, and advanced health testing ...

The U.S. Food and Drug Administration (FDA) has approved Myrio Therapeutics' Investigational New Drug (IND) application for its lead product, PHOX2B PC-CAR T, paving the way for human trials in ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Topline results from the chronic cohort of an ongoing phase 1b/2a clinical trial of an investigational therapeutic peptide, NVG-291, found the novel treatment led to increased electrical connectivity ...

Some of the available monoclonal antibodies to treat migraine include erenumab, fremanezumab, galcanezumab, and eptinezumab.

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

846-P - Safety, Pharmacokinetics, and Pharmacodynamics of MBX 1416, a Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy Volunteers: A Phase 1 Randomized Trial Presenter: Elisa Fabbrini, MD. PhD.

For decades, the tools of male anti-ageing were predictable: a discreet prescription for the little blue pill, a secret stash ...